Overview
TLC-SMG is a 31 amino acid GLP-1 analogue with two amino acid substitutions and a C18 fatty diacid side chain attached through a linker.
Research context
It is used in GLP-1 receptor pharmacology, including receptor binding and signalling assays and preclinical models of metabolic signalling.
Specifications
- Form: Lyophilized powder
- Quantity: 10 mg or 30 mg per vial (select size)
- Container: 3 mL glass vial, sealed
- Storage: Minus 20 °C, dry and protected from light
- Documentation: Lot-specific Certificate of Analysis (identity and purity by HPLC-MS), matched to the batch number on the label
For laboratory research use only. Not a drug, food, cosmetic or medical device. Not for human or animal use of any kind. No usage guidance is provided.


